Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

被引:1
|
作者
Pericoli, Giulia [1 ]
Ferretti, Roberta [1 ]
Moore, Andrew S. [2 ,3 ]
Vinci, Maria [1 ]
机构
[1] IRCCS, Bambino Gesu Childrens Hosp, Dept Oncohematol Gene & Cell Therapy, Rome, Italy
[2] Childrens Hlth Queensland Hosp & Hlth Serv, Oncol Serv, South Brisbane, Qld, Australia
[3] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia
来源
关键词
CANCER;
D O I
10.3791/63091
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cell migration and invasion are specific hallmarks of Diffuse Midline Glioma (DMG) H3K27M-mutant tumors. We have already modeled these features using three-dimensional (3D) cell-based invasion and migration assays. In this study, we have optimized these 3D assays for live-cell immunocytochemistry. An Antibody Labeling Reagent was used to detect in real-time the expression of the adhesion molecule CD44, on the plasma membrane of migrating and invading cells of a DMG H3K27M primary patient-derived cell line. CD44 is associated with cancer stem cell phenotype and tumor cell migration and invasion and is involved in the direct interactions with the central nervous system (CNS) extracellular matrix. Neurospheres (NS) from the DMG H3K27M cell line were embedded into the basal membrane matrix (BMM) or placed onto a thin coating layer of BMM, in the presence of an anti-CD44 antibody in conjunction with the antibody labeling reagent (ALR). The live-3D-cell immunocytochemistry image analysis was performed on a live-cell analysis instrument to quantitatively measure the overall CD44 expression, specifically on the migrating and invading cells. The method also allows visualizing in real-time the intermittent expression of CD44 on the plasma membrane of migrating and invading cells. Moreover, the assay also provided new insights into the potential role of CD44 in the mesenchymal to amoeboid transition in DMG H3K27M cells.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] DISSECTING THE ECOSYSTEM OF PEDIATRIC DIFFUSE MIDLINE GLIOMA
    Morscio, Julie
    Jacobs, Sandra
    De Smet, Frederik
    NEURO-ONCOLOGY, 2024, 26
  • [2] Reirradiation of pediatric patients with diffuse midline glioma
    Ostergaard, D.
    Vogelius, I. R.
    Mathiasen, R.
    Nysom, K.
    Jorgensen, M.
    Sehested, A. M.
    Maraldo, M.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S676 - S677
  • [3] A road map for the treatment of pediatric diffuse midline glioma
    Koschmann, Carl
    Al-Holou, Wajd N.
    Alonso, Marta M.
    Anastas, Jamie
    Bandopadhayay, Pratiti
    Barron, Tara
    Becher, Oren
    Cartaxo, Rodrigo
    Castro, Maria G.
    Chung, Chan
    Clausen, Madison
    Dang, Derek
    Doherty, Robert
    Duchatel, Ryan
    Dun, Matthew
    Filbin, Mariella
    Franson, Andrea
    Galban, Stefanie
    Moure, Marc Garcia
    Garton, Hugh
    Gowda, Pruthvi
    Marques, Joana Graca
    Hawkins, Cynthia
    Heath, Allison
    Hulleman, Esther
    Ji, Sunjong
    Jones, Chris
    Kilburn, Lindsay
    Kline, Cassie
    Koldobskiy, Michael A.
    Lim, Daniel
    Lowenstein, Pedro R.
    Lu, Q. Richard
    Lum, Joanna
    Mack, Stephen
    Magge, Suresh
    Marini, Bernard
    Messinger, Dana
    Martin, Donna
    Marupudi, Neena
    Mody, Rajen
    Morgan, Meredith
    Mota, Mateus
    Muraszko, Karin
    Mueller, Sabine
    Natarajan, Siva Kumar
    Nazarian, Javad
    Niculcea, Michael
    Nuechterlein, Nicholas
    Okada, Hideho
    CANCER CELL, 2024, 42 (01) : 1 - 5
  • [4] The role of brainstem biopsy and targeted therapies in pediatric diffuse midline glioma/diffuse intrinsic pontine glioma
    Sheikh, Shehryar R.
    Recinos, Violette M. R.
    Thompson, Eric M.
    Mangum, Ross
    Wright-Nadkarni, Mariah
    Gampel, Bradley
    Patel, Neha J.
    Natl Pediat Canc Fdn NPCF Cent Nervous Syst Task Force
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] CAR T cell therapies for diffuse midline glioma
    Thomas, Bryce C.
    Staudt, Dilana E.
    Douglas, Alicia M.
    Monje, Michelle
    Vitanza, Nicholas A.
    Dun, Matthew D.
    TRENDS IN CANCER, 2023, 9 (10): : 791 - 804
  • [6] Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
    Daphne Li
    Erin R. Bonner
    Kyle Wierzbicki
    Eshini Panditharatna
    Tina Huang
    Rishi Lulla
    Sabine Mueller
    Carl Koschmann
    Javad Nazarian
    Amanda M. Saratsis
    Scientific Reports, 11
  • [7] STANDARDIZATION OF LIQUID BIOPSY FOR PEDIATRIC DIFFUSE MIDLINE GLIOMA USING DDPCR
    Li, Daphne
    Bonner, Erin
    Huang, Tina
    Koschmann, Carl
    Nazarian, Javad
    Saratsis, Amanda
    NEURO-ONCOLOGY, 2023, 25
  • [8] Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
    Li, Daphne
    Bonner, Erin R.
    Wierzbicki, Kyle
    Panditharatna, Eshini
    Huang, Tina
    Lulla, Rishi
    Mueller, Sabine
    Koschmann, Carl
    Nazarian, Javad
    Saratsis, Amanda M.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] TARGETING THE METABOLIC ERK5-PFKFB3 AXIS IN PEDIATRIC DIFFUSE MIDLINE GLIOMA
    Casillo, Stephanie
    Gatesman, Taylor
    Chilukuri, Akanksha
    Jane, Esther
    Premkumar, Daniel
    Barber, Callie
    Halbert, Matthew
    Cruz, Andrea
    Mullett, Steven
    Michel, Joshua
    Chang, Yue-Fang
    MichaelRaj, Antony
    Lieberman, Frank
    Felker, James
    Shiva, Sruti
    Abdullah, Kalil
    Zinn, Pascal
    Friedlander, Robert
    Abel, Taylor
    Venneti, Sriram
    Mack, Stephen
    Wendell, Stacy
    Pollack, Ian
    Agnihotri, Sameer
    NEURO-ONCOLOGY, 2023, 25
  • [10] Extracellular Histones Profiles of Pediatric H3K27-Altered Diffuse Midline Glioma
    Buzova, Diana
    Petrilli, Lucia Lisa
    Frohlich, Jan
    Tsoneva, Desislava K.
    Bianco, Salvatore Daniele
    Braghini, Maria Rita
    Alisi, Anna
    Mastronuzzi, Angela
    Cerveny, Jan
    Mazza, Tommaso
    Vinci, Maria
    Vinciguerra, Manlio
    MOLECULAR DIAGNOSIS & THERAPY, 2025, 29 (01) : 129 - 141